Leishmaniasis, Cutaneous - 18 Studies Found

Completed : Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2006-04-21
:
  • Drug: Meglumine antimoniate Me
Active, not recruiting : Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2011-02-20
: Drug: Meglumine antimoniate Meglumine antimoniate is store
Active, not recruiting : Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
: Cutaneous Leishmaniasis
: 2007-06-14
:
  • Drug: Miltefosine Oral Miltefo
Completed : Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
: Cutaneous Leishmaniasis
: 2013-02-05
:
  • Drug: WR 279,396 WR 279,396 is
Completed : Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
: Cutaneous Leishmaniasis
: 1999-11-03
: Biological: Combination of autoclaved leishmania antigen with recombinant human interleukin-12 (rhIL-12) and aluminum hydroxide gel as adjuvants
Terminated : Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony
: Cutaneous Leishmaniasis
: 2009-01-28
:
  • Drug: Miltefosine and antimony

Completed : Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2008-05-07
:
  • Drug: Miltefosine + Imiquimod

RECRUITING : Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis
: Leishmaniasis, Cutaneous
: 2024-11-21
: Sessions will be held once weekly for a maximum of 6 weeks
<<< Previous